Fundz

Merakris Therapeutics Appoints Roger Ilagan as Chief Scientific Officer

PRIVATEApr 10, 2025

Position

Chief Scientific Officer

Company

Merakris Therapeutics

Roger Ilagan
rilagan@merakris.com
Research Triangle ParkManufacturingBiotechnologyHealth CareTherapeutics

Description

Merakris Therapeutics has appointed Roger Ilagan, PhD, as its new Chief Scientific Officer. Dr. Ilagan will oversee the biologic drug development for their advanced wound care technology

Who to call at Merakris Therapeutics, and when

A new leader at Merakris Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day Merakris Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Merakris Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Merakris Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Merakris Therapeutics

Location

Research Triangle Park, North Carolina, United States

About

Merakris Therapeutics is a leading innovator in regenerative medicine focused on developing and commercializing biologically derived products for wound healing and other complex conditions. Leveraging advanced biologic manufacturing capabilities and a robust research pipeline, Merakris is committed to improving patient outcomes and advancing the science of regenerative therapies.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Merakris Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Roger
Likely contact at this company
••••••••@••••••••

See Roger's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Merakris Therapeutics's next move

Learn about Strategic plan

Merakris Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.